Format

Send to

Choose Destination
Curr Opin Chem Biol. 2000 Aug;4(4):433-9.

New approaches in the treatment of bacterial infections.

Author information

1
The RW Johnson Pharmaceutical Research Institute, Raritan, NJ 08869, USA. kbush@prius.jnj.com

Abstract

Recently, several new drugs for the treatment of bacterial infections have been developed. Quinupristin/dalfopristin, moxifloxacin and gatifloxacin have been approved throughout the world for clinical use. Levofloxacin has been approved for the treatment of community-acquired pneumonia caused by penicillin-resistant Streptococcus pnuemoniae. The Food and Drug Administration has approved linezolid for clinical use, and new drug applications for gemifloxacin and telithromycin were filed. Other new targets have surfaced in the quest for novel antibacterial agents.

PMID:
10959772
DOI:
10.1016/s1367-5931(00)00106-x
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center